Tomato lycopene and lung cancer prevention: from experimental to human studies

Area of Science:

• Nutritional Science
• Oncology
• Molecular Biology

Background:

• Emerging evidence suggests tomato lycopene possesses anti-cancer properties, particularly against lung cancer.
• Experimental studies indicate lycopene's potential to inhibit lung cancer cell growth and tumorigenesis through various biological mechanisms.

Purpose of the Study:

• To review the cancer-preventive activities of lycopene, focusing on lung cancer.
• To explore the underlying mechanisms of lycopene's anti-cancer effects.
• To assess the current understanding of lycopene's role in human lung cancer risk.

Main Methods:

• Review of experimental studies on lycopene's effects on lung cancer cells and animal models.
• Analysis of proposed mechanisms including redox modulation, cell cycle regulation, apoptosis, growth factor signaling, and inflammation.
• Examination of lycopene's impact on cell invasion, angiogenesis, and metastasis.

Main Results:

• Lycopene demonstrated inhibitory effects on lung cancer cell growth, tumorigenesis, invasion, angiogenesis, and metastasis in experimental settings.
• Identified mechanisms include modulation of redox status, induction of apoptosis, regulation of growth factors, and reduction of inflammation.
• Lycopene metabolites may also contribute to its cancer-preventive effects.

Conclusions:

• Lycopene exhibits promising anti-cancer activities against lung cancer in preclinical studies.
• Further well-controlled clinical trials are essential to establish a direct link between lycopene consumption and reduced human lung cancer risk.
• Future research should address factors like subject selection, analytical markers, dosage, metabolism, and interactions with other dietary components.